# CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

> **NCT02918084** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy** · enrollment: 1000 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Anastrozole or Letrozole or Exemestane
- **DRUG:** Anastrozole or Letrozole or Exemestane

## Key facts

- **NCT ID:** NCT02918084
- **Lead sponsor:** IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-06
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918084, "CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02918084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*